Inveniam intends to take up this challagence by offering a quality service for the efficient assessment, measurement and integration of ESG criteria in the analysis of investments, transforming financial information into financial-social information.
At Inveniam Group, we would like to congratulate Dr. Rafael Correa Rocha, head of the Immune-Regulation Laboratory of Gregorio Marañón Hospital, for participating in a European consortium that promotes research on cellular immunotherapies to cope with Covid-19. The consortium is coordinated by the Hospital Clínic de Barcelona – IDIBAPS with support of the company Cellnex…
Time is Brain is developing a new class medical device to improve the diagnosis, treatment, and follow-up of the patient with acutre ischemic stroke.
Time is Brain
Spain
Inveniam supported the company in winning an EIT Health Headstart
Public Funding from EU
Public Funding 2020
Miwendo
Spain
Inveniam supported the company in winning an EIC Accelerator grant
Public Funding from EU
Public Funding 2020
Pharmacelera
Spain
Inveniam supported the company in winning an EIC Accelerator grant
Public Funding from EU
Public Funding 2020
Socrates Consortium
Spain
Inveniam supported in the presentation for the Interactive Technologies call
Public Funding from EU
Public Funding 2020
Devicare
Spain
Inveniam advised in the Series A round closing a deal with Successful Ventures
Equity Fundraising
Financial Services & Transaction Advisory 2020
TedCas
Spain
Inveniam advised the company in a seed round with business angels
Equity Fundraising
Financial Services & Transaction Advisory 2019
Símbiosy
Spain
Inveniam supported the company in winning the SME Instrument Phase I
Public Funding from EU
Public Funding 2019
Wiretronic
Sweden
Inveniam supported the company in winning the SME Instrument Phase I
Public Funding from EU
Public Funding 2019
